Babesia are tick-transmitted protozoan parasites that infect mammals. Human babesiosis, also transmitted by blood transfusion, is an increasing global public health risk.1
Symptoms of Babesia infection include the presence of fever, fatigue and malaise, followed by anemia, hemoglobinuria, anorexia, emaciation, and vomiting. The acute hemolytic phase of severe infection can result in death in immunosuppressed people.1
Recovery from babesiosis utilizing existing drugs may take months or years in immunosuppressed patients. Case reports suggest tafenoquine at doses approved by FDA for malaria may address this problem.2,3*
Cases and 1 Million+ deaths in the U.S. from COVID-19 infections
Annual deaths from malaria globally
Travelers to malaria endemic regions per annum
Annual dengue infections globally
1025 Connecticut Ave. NW, Suite 1000, Washington, DC 20036